Contact Us |

Search 

עברית  

    logoemp

 

slogN

 

dayanews emp nodaya

 

 18 | February | 2015

Significant Findings in U.S. National Institutes of Health’s Trial of Pluristem’s PLX-R18 Cells for Treatment of Acute Radiation Syndrome

Read more >


 2 | February | 2015

Pluristem Announces Significant New Finding from its Phase I/II Muscle Injury Trial and Excellent Safety Profile for PLX-PAD Cells at Twelve Months

Read more >


 13 | January | 2015

Pluristem to Present at Two Cell Therapy Conferences in January 2015

Read more >


 12 | January | 2015

Pluristem Issues Letter to Shareholders

Read more >


 
 
 
 
About hp
 

 

Zami Aberman

Zami Aberman

Chairman and CEO

From the CEO

 

Our vision at Pluristem Therapeutics is to leverage our position as a global leader in placenta-based cell science to develop and manufacture safe and effective cell therapy products. We believe our cutting edge technology can produce therapies that will help people affected by inflammation, ischemia, hematological disorders, and acute radiation syndrome, and establish us as a leading company in the cell therapy arena. We also believe that in cell therapy “the process is the product”, and precise control of the entire process, from obtaining cells from the source, to delivery to the patient, is vital to the success of a cell therapy. Our fully automated process, proprietary 3D cell expansion technology and increasing knowledge of the placental cell drive us to continue developing additional candidates for our product portfolio.

 

Zami Aberman
Chairman and CEO

 

Significant Findings in U.S. National Institutes of Health’s Trial of Pluristem’s PLX-R18 Cells for Treatment of Acute Radiation Syndrome - click here

 

 

 

Pluristem Video

 

 

 

 

 

NIH slide

 catom 01

catom 03

catom 05

catom 07

catom 09

catom 11

catom 13

 

 

 

catom 02

Share Button
 

The content, text, graphics, data, and services offered herein (the "Content") are provided solely to educate users of this web site on Pluristem and the goods and/or services it provides.  Nothing in the Content should be considered, or used as a substitute for, medical advice, diagnosis or treatment.  Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.  Reliance on the Content or any portion thereof, or other visitors to the web site, is solely at your own risk.